“The current political morass in Washington allowed the SBIR program to expire, placing two grants, $3.4M and our drug development program at risk. If resolved quickly, this would represent only a speed bump in our timeline. If not, it could risk our entire program as we're attempting to navigate the infamous "valley of death"; the gap between government and venture capital funding.”

“I personally witnessed the SBIR program change the treatment of patients with life-threatening blood clots in their lungs…..

Without the SBIR program support, this trial might not have happened, and the 900,000 per year in the U.S. who experience pulmonary embolism would not have this innovative drug-device combination therapy available to them.”

“Venture capital is essential non existent in the state of Louisiana so these award funds have been game changers for us.”

“But for me to know that one person won't spiral down the addiction pathway - that would not have happened without the funding.”